Correlation Between Stryker and Quipt Home
Can any of the company-specific risk be diversified away by investing in both Stryker and Quipt Home at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Quipt Home into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stryker and Quipt Home Medical, you can compare the effects of market volatilities on Stryker and Quipt Home and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Quipt Home. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Quipt Home.
Diversification Opportunities for Stryker and Quipt Home
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Stryker and Quipt is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Quipt Home Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quipt Home Medical and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Quipt Home. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quipt Home Medical has no effect on the direction of Stryker i.e., Stryker and Quipt Home go up and down completely randomly.
Pair Corralation between Stryker and Quipt Home
Considering the 90-day investment horizon Stryker is expected to under-perform the Quipt Home. But the stock apears to be less risky and, when comparing its historical volatility, Stryker is 3.37 times less risky than Quipt Home. The stock trades about 0.0 of its potential returns per unit of risk. The Quipt Home Medical is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 264.00 in Quipt Home Medical on December 1, 2024 and sell it today you would earn a total of 0.00 from holding Quipt Home Medical or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Stryker vs. Quipt Home Medical
Performance |
Timeline |
Stryker |
Quipt Home Medical |
Stryker and Quipt Home Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Stryker and Quipt Home
The main advantage of trading using opposite Stryker and Quipt Home positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Quipt Home can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quipt Home will offset losses from the drop in Quipt Home's long position.Stryker vs. Boston Scientific Corp | Stryker vs. Abbott Laboratories | Stryker vs. Medtronic PLC | Stryker vs. DexCom Inc |
Quipt Home vs. Tela Bio | Quipt Home vs. Treace Medical Concepts | Quipt Home vs. Pulmonx Corp | Quipt Home vs. Profound Medical Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data |